Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04766216 · ClinicalTrials.gov registry record · NA
Warfarin Patient Self-management Implementation in the US Healthcare System
A NA study of Atrial Fibrillation and Venous Thromboembolism, sponsored by University of Utah.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 4
- Study locations
NCT04766216: Recruiting NA study of Atrial Fibrillation and Venous Thromboembolism, sponsored by University of Utah.
NCT04766216 is a NA study of Atrial Fibrillation and Venous Thromboembolism that is actively recruiting participants, run by University of Utah. The registered enrollment target is 150 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (95% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04766216, a NA study of Atrial Fibrillation and Venous Thromboembolism, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 4
- Study locations
Study Summary
In the US, patients receiving warfarin therapy are rarely allowed to engage in patient self-management (PSM) which is less burdensome, less expensive, and safer than standard clinic-directed warfarin management. The long-term objective of our application is to improve the safety of ambulatory warfarin therapy through increasing the implementation of PSM.
Conditions Studied
Interventions
- OTHER Patient self-management
- OTHER Usual care provided by anticoagulation providers
Study Locations (4)
California
- VA Loma Linda Healthcare System - Loma Linda
Massachusetts
- Brigham and Women's Hospital - Boston
Michigan
- University of Michigan - Ann Arbor
Utah
- University of Utah Thrombosis Center - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-03-15 |
| Est. Completion | 2025-04-30 |
| Phase | NA |
What NCT04766216 shows while recruiting
NCT04766216 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (95% lower).
The record links to 3 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 2 interventions - of which Patient self-management is the first listed.
NCT04766216 reports a single indexed study location in California, Massachusetts, Michigan.
Frequently Asked Questions
What is clinical trial NCT04766216 about?
NCT04766216 is a clinical study titled "Warfarin Patient Self-management Implementation in the US Healthcare System". In the US, patients receiving warfarin therapy are rarely allowed to engage in patient self-management (PSM) which is less burdensome, less expensive, and safer than standard clinic-directed warfarin management. The long-term objective of our application is to improve the safety of ambulatory warfar...
What is the current status of trial NCT04766216?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-03-15. Estimated completion is 2025-04-30.
What conditions does trial NCT04766216 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Venous Thromboembolism, Heart Valve Diseases.
What interventions are being tested in trial NCT04766216?
The interventions under investigation include: Patient self-management (OTHER), Usual care provided by anticoagulation providers (OTHER).
Who is sponsoring clinical trial NCT04766216?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04766216 being conducted?
This trial has 4 study locations across California, Massachusetts, Michigan, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04766216's enrollment target sits among peer trials
150 119th of 202 higher than 81 of 202 other Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
-
The CONFORM Pivotal Trial
RECRUITING · NA
-
Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
RECRUITING · NA
-
The Fourth Left Atrial Appendage Occlusion Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI